Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial

• Main Authors: Hee-Yeon Shin (Author), Tae-Bin Yim (Author), Hye-Min Heo (Author), Geon-Ho Jahng (Author), Seungwon Kwon (Author), Seung-Yeon Cho (Author), Seong-Uk Park (Author), Woo-Sang Jung (Author), Sang-Kwan Moon (Author), Chang-Nam Ko (Author), Jung-Mi Park (Author)
• Formato: Livro
• Publicado em: BMC, 2022-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Amnestic mild cognitive impairment (aMCI) is often considered a precursor to Alzheimer's disease (AD) and represents a key therapeutic target for early intervention of AD. However, no treatments have been approved for MCI at present. Our previous pilot study has shown that K...